Compare
Arcadia Biosciences, Inc. vs Innovation Beverage Group Ltd vs IP Strategy Holdings, Inc. vs MDWerks, Inc.
| Latest fiscal year | Arcadia Biosciences, Inc. RKDA | Innovation Beverage Group Ltd IBG | IP Strategy Holdings, Inc. IPST | MDWerks, Inc. MDWK |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $4.86M | $2.77M | $10.12M | $2.21M |
| Revenue growth (YoY) | -3.7% | -5.1% | +20.4% | -6.3% |
| Gross margin | 36.2% (computed) | 44.2% | 54.9% | -15.8% |
| Operating margin | -51.5% | -194.2% | n/m | -168.7% |
| Net margin | -48.1% | -223.4% | n/m | -171.5% |
| Net income | -$2.34M | -$6.19M | -$137.72M | -$3.80M |
| EPS (Diluted) | -$1.71 | -$13.09 | -$16.03 | -$0.02 |
| Operating cash flow | -$4.74M | -$1.56M | -$15.33M | -$1.57M |
| Free cash flow | -$4.74M | -$1.57M | -$15.40M | -$2.45M |
| Cash & equivalents | $259.0K | $127.8K | n/a | n/a |
| Total assets | $6.55M | $1.29M | $108.76M | $4.05M |
| Total liabilities | $2.41M | $2.76M | $10.54M | $3.05M |
| Shareholders' equity | $4.14M | -$1.47M | $98.22M | $1.00M |
| Return on year-end equity | -56.5% | n/a | -140.2% | -378.9% |
| Shares outstanding | 1.37M | 347.0K | 9.65M | 234.11M |
Revenue, most recent five fiscal years
| Fiscal year | Arcadia Biosciences, Inc. | Innovation Beverage Group Ltd | IP Strategy Holdings, Inc. | MDWerks, Inc. |
|---|---|---|---|---|
| Latest | $4.86M Ended 2025-12-31 | $2.77M Ended 2025-12-31 | $10.12M Ended 2025-12-31 | $2.21M Ended 2025-12-31 |
| 1 year earlier | $5.04M Ended 2024-12-31 | $2.92M Ended 2024-12-31 | $8.40M Ended 2024-12-31 | $2.36M Ended 2024-12-31 |
| 2 years earlier | $4.45M Ended 2023-12-31 | $3.15M Ended 2023-12-31 | $7.97M Ended 2023-12-31 | $104.1K Ended 2023-12-31 |
| 3 years earlier | $7.42M Ended 2022-12-31 | n/a | n/a | n/a |
| 4 years earlier | $6.78M Ended 2021-12-31 | n/a | n/a | n/a |